142 related articles for article (PubMed ID: 9096196)
21. Safety and efficacy of multilamellar liposomal nystatin against disseminated candidiasis in persistently neutropenic rabbits.
Groll AH; Petraitis V; Petraitiene R; Field-Ridley A; Calendario M; Bacher J; Piscitelli SC; Walsh TJ
Antimicrob Agents Chemother; 1999 Oct; 43(10):2463-7. PubMed ID: 10508025
[TBL] [Abstract][Full Text] [Related]
22. Pharmacokinetics of conventional formulation versus fat emulsion formulation of amphotericin B in a group of patients with neutropenia.
Ayestarán A; López RM; Montoro JB; Estíbalez A; Pou L; Julià A; López A; Pascual B
Antimicrob Agents Chemother; 1996 Mar; 40(3):609-12. PubMed ID: 8851579
[TBL] [Abstract][Full Text] [Related]
23. Efficacy of alternative dosing regimens of poly-aggregated amphotericin B.
Espada R; Valdespina S; Molero G; Dea MA; Ballesteros MP; Torrado JJ
Int J Antimicrob Agents; 2008 Jul; 32(1):55-61. PubMed ID: 18534826
[TBL] [Abstract][Full Text] [Related]
24. Prospective study of Candida colonization, use of empiric amphotericin B and development of invasive mycosis in neutropenic patients.
Martino P; Girmenia C; Micozzi A; De Bernardis F; Boccanera M; Cassone A
Eur J Clin Microbiol Infect Dis; 1994 Oct; 13(10):797-804. PubMed ID: 7889948
[TBL] [Abstract][Full Text] [Related]
25. Lipid emulsion reduces subacute toxicity of amphotericin B: a histopathological study.
Souza LC; Saldiva PH; Campa A
Exp Toxicol Pathol; 2000 May; 52(2):169-75. PubMed ID: 10965993
[TBL] [Abstract][Full Text] [Related]
26. Efficacy of a new formulation of amphotericin B in a murine model of disseminated infection by Candida glabrata.
Mariné M; Espada R; Torrado J; Pastor FJ; Guarro J
J Antimicrob Chemother; 2008 Apr; 61(4):880-3. PubMed ID: 18256113
[TBL] [Abstract][Full Text] [Related]
27. Effects of the hematoregulatory peptide SK&F 107647 alone and in combination with amphotericin B against disseminated candidiasis in persistently neutropenic rabbits.
Lyman CA; Gonzalez C; Schneider M; Lee J; Walsh TJ
Antimicrob Agents Chemother; 1999 Sep; 43(9):2165-9. PubMed ID: 10471559
[TBL] [Abstract][Full Text] [Related]
28. [Emulsion of amphotericin B in Intralipid 20%: in vitro and in vivo efficacy].
Chavanet P; Charlier N; Brenet A; Goux A; Muggéo E; Caillot D; Casasnovas O; Kistermann JP; Waldner A; Portier H
Pathol Biol (Paris); 1992 May; 40(5):507-12. PubMed ID: 1495835
[TBL] [Abstract][Full Text] [Related]
29. Amphotericin B in children with malignant disease: a comparison of the toxicities and pharmacokinetics of amphotericin B administered in dextrose versus lipid emulsion.
Nath CE; Shaw PJ; Gunning R; McLachlan AJ; Earl JW
Antimicrob Agents Chemother; 1999 Jun; 43(6):1417-23. PubMed ID: 10348763
[TBL] [Abstract][Full Text] [Related]
30. Randomized comparison of amphotericin B deoxycholate dissolved in dextrose or Intralipid for the treatment of AIDS-associated cryptococcal meningitis.
Joly V; Aubry P; Ndayiragide A; Carrière I; Kawa E; Mlika-Cabanne N; Aboulker JP; Coulaud JP; Larouze B; Yeni P
Clin Infect Dis; 1996 Sep; 23(3):556-62. PubMed ID: 8879780
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of antibody-bearing liposomal amphotericin B in the treatment of systemic candidiasis in a neutropenic murine model.
Belay T; Hospenthal DR; Rogers AL; Patterson MJ
J Med Vet Mycol; 1991; 29(6):419-21. PubMed ID: 1815035
[TBL] [Abstract][Full Text] [Related]
32. Treatment of systemic candidiasis in a neutropenic murine model using immunoglobulin G bearing liposomal amphotericin B.
Belay T; Hospenthal DR; Rogers AL; Patterson MJ
Mycopathologia; 1993 Jul; 123(1):9-17. PubMed ID: 8247096
[TBL] [Abstract][Full Text] [Related]
33. Experimental basis for use of fluconazole for preventive or early treatment of disseminated candidiasis in granulocytopenic hosts.
Walsh TJ; Lee J; Aoki S; Mechinaud F; Bacher J; Lecciones J; Thomas V; Rubin M; Pizzo PA
Rev Infect Dis; 1990; 12 Suppl 3():S307-17. PubMed ID: 2184509
[TBL] [Abstract][Full Text] [Related]
34. Efficacy evaluation of a novel submicron amphotericin B emulsion in murine candidiasis.
Levy MY; Polacheck I; Barenholz Y; Benita S
J Med Vet Mycol; 1993; 31(3):207-18. PubMed ID: 8360812
[TBL] [Abstract][Full Text] [Related]
35. Experimental intraabdominal candidiasis in rabbits: therapy with low-total-dose intravenous amphotericin B.
Bayer AS; Edwards JE; Guze LB
Antimicrob Agents Chemother; 1981 Jan; 19(1):179-84. PubMed ID: 7247356
[TBL] [Abstract][Full Text] [Related]
36. In-vitro and in-vivo studies of the decrease of amphotericin B toxicity upon association with a triglyceride-rich emulsion.
Souza LC; Maranhão RC; Schreier S; Campa A
J Antimicrob Chemother; 1993 Jul; 32(1):123-32. PubMed ID: 8226403
[TBL] [Abstract][Full Text] [Related]
37. Activity of aminocandin (IP960) compared with amphotericin B and fluconazole in a neutropenic murine model of disseminated infection caused by a fluconazole-resistant strain of Candida tropicalis.
Warn PA; Sharp A; Morrissey G; Denning DW
J Antimicrob Chemother; 2005 Sep; 56(3):590-3. PubMed ID: 16046462
[TBL] [Abstract][Full Text] [Related]
38. Therapy with amphotericin B of Candida septicemia in the presence of acute renal failure.
Richardson JA; Derrow AM; Borchardt KA
Invest Urol; 1968 Nov; 6(3):247-50. PubMed ID: 5697021
[No Abstract] [Full Text] [Related]
39. Liposome-encapsulated amphotericin B for treatment of disseminated candidiasis in neutropenic mice.
Lopez-Berestein G; Hopfer RL; Mehta R; Mehta K; Hersh EM; Juliano RL
J Infect Dis; 1984 Aug; 150(2):278-83. PubMed ID: 6470530
[TBL] [Abstract][Full Text] [Related]
40. Administration of amphotericin B in lipid emulsion.
O'Neil MG; Lapointe M
Crit Care Med; 1997 May; 25(5):892-3; author reply 893-4. PubMed ID: 9187614
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
